Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Apr;48(4):1361-4.
doi: 10.1128/AAC.48.4.1361-1364.2004.

Increasing prevalence of methicillin-resistant Staphylococcus aureus causing nosocomial infections at a university hospital in Taiwan from 1986 to 2001

Po-Ren Hsueh  1 , Lee-Jene Teng, Wen-Hwei Chen, Huei-Ju Pan, Mei-Lin Chen, Shan-Chwen Chang, Kwen-Tay Luh, Fang-Yue Lin
Affiliations

Increasing prevalence of methicillin-resistant Staphylococcus aureus causing nosocomial infections at a university hospital in Taiwan from 1986 to 2001

Po-Ren Hsueh et al. Antimicrob Agents Chemother. 2004 Apr.

Abstract

A rapid emergence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection (from 26.3% in 1986 to 77% in 2001) was found. The susceptibility of 200 nonduplicate blood isolates of MRSA and 100 MRSA isolates causing refractory bacteremia to 22 antimicrobial agents disclosed that glycopeptides, quinupristin-dalfopristin, and linezolid remained the most active agents.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Incidence of nosocomial bloodstream infections caused by S. aureus and distribution of S. aureus among all pathogens causing nosocomial bloodstream infections at the NTUH, 1981 to 2001.
FIG. 2.
FIG. 2.
Association between the prevalence of oxacillin-resistant S. aureus (MRSA) causing nosocomial infections and annual consumption (defined daily dose [DDD] per 1,000 patient-days) of extended-spectrum cephalosporins (cefotaxime, ceftriaxone, ceftazidime, cefepime, and cefpirome), carbapenems (imipenem and meropenem), ciprofloxacin, and glycopeptides (vancomycin and teicoplanin) at the NTUH, 1986 to 2001.
See this image and copyright information in PMC

References

    1. Anonymous. 2002. Staphylococcus aureus resistant to vancomycin—United States. Morb. Mortal. Wkly. Rep. 51:565-567. - PubMed
    1. Anonymous. 1999. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1990-May 1999, issued June 1999. Am. J. Infect. Control 27:520-532. - PubMed
    1. Bell, J. M., J. D. Turnidge, and SENTRY APAC Participants. 2002. High prevalence of oxacillin-resistant Staphylococcus aureus isolates from hospitalized patients in Asia-Pacific and South Africa: results from SENTRY Antimicrobial Surveillance Program, 1998-1999. Antimicrob. Agents Chemother. 46:879-881. - PMC - PubMed
    1. Canton, R., E. Loza, M. I. Morosini, and F. Baquero. 2001. Antimicrobial resistance amongst isolates of Streptococcus pyogenes and Staphylococcus aureus in the PROTEKT antimicrobial surveillance programme during 1999-2000. J. Antimicrob. Chemother. 50(Suppl. S1):9-24. - PubMed
    1. Chambers, H. F. 2001. The changing epidemiology of Staphylococcus aureus? Emerg. Infect. Dis. 7:178-182. - PMC - PubMed

MeSH terms